131875-08-6
Chemical Structure
Lexacalcitol
Synonym(s): KH1060
- CAS No.: 131875-08-6
- Formula:C29H48O4
- Molecular Weight:460.69
IUPAC Name: (1R,3S,Z)-5-(2-((1S,3aS,7aS,E)-1-((R)-1-((4-ethyl-4-hydroxyhexyl)oxy)ethyl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
InChIKey: KLZOTDOJMRMLDX-YBBVPDDNSA-N
SMILES: C[C@]1(CCC/2)[C@](CC[C@@H]1[C@@H](C)OCCCC(CC)(CC)O)([H])C2=C\C=C(C[C@@H](O)C[C@@H]3O)/C3=C
Biological Activity: Lexacalcitol (KH1060), a vitamin D analog, is a potent regulator of cell growth and immune responses. Lexacalcitol can be used for the research of graft rejection, psoriasis, cancer and auto-immune diseases[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lexacalcitol | Lexacalcitol (KH1060), a vitamin D analog, is a potent regulator of cell growth and immune responses. Lexacalcitol can be used for the research of graft rejection, psoriasis, cancer and auto-immune diseases. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.93
HY-100219CB1151 -
Similarity Score 0.86
HY-32339Maxacalcitol -
Similarity Score 0.85
HY-117638CB 966 -
Similarity Score 0.78
HY-77274Calcitriol Impurities D -
Similarity Score 0.78
HY-10002AR(1S)-Calcitriol (Standard) -
Similarity Score 0.78
HY-10002B(1R,5Z)-Calcitriol -
Similarity Score 0.78
HY-10002RCalcitriol (Standard) -
Similarity Score 0.78
HY-13292Impurity B of Calcitriol -
Similarity Score 0.78
HY-150663SCalcitriolc -
Explore the MedChemAI to find more analogs
References
- [1]. L Binderup, et al. 20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol. 1991 Sep 27;42(8):1569-75. [Content Brief]
- [2]. C Gysemans, et al. A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice. Transplant Proc. 2001 May;33(3):2365. [Content Brief]
